Trails Edge Biotechnology Offshore Fund, LP

Amendment
CIK: 0002070384·Pooled Investment Fund·CAYMAN ISLANDS·Filed: Jun 25, 2026
Total Offering

Indefinite

Amount Sold

$292,874,003

Investors

36

First Sale

Jul 1, 2025

Offering Details

Type
Pooled Investment Fund
Exemptions
Rule 506(b), Section 3(c), Section 3(c)(7)
Entity Type
Other
Year Incorporated
2025
Non-Accredited Investors
No

Related Persons

NameRole
- Trails Edge Biotechnology Fund GP, LP
- Trails Edge Capital Partners, LP
Ortav Yehudai
Matthew Diaz

Company

Trails Edge Biotechnology Offshore Fund, LP

3445 PEACHTREE ROAD NE

ATLANTA, GA, 30326

770-600-9010

SEC Filing

0001493152-26-030079

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
Trails Edge Biotechnology Offshore Fund, LP Form D Filing — Indefinite | FilingFlow